The Springboard Health Angels
Dr. Stephanie Oestreich
Managing Director at Myeloma Investment Fund (MIF), board member at multiple prestigious institutions, and faculty at MIT. Stephanie brings a wealth of experience from her roles in Pharma, Biotech, and Venture . With a Ph.D. in biochemistry and an MPA from Harvard, she combines scientific expertise with strategic insight
Dr. Eric Yang
Eric is an experienced professional in drug development, utilizing ML/AI and other computational tools to efficiently retarget therapies to new patients. He has experience in drug development at major pharmaceutical companies such as J&J and Novartis as well as experience in the payor space at Aetna. Currently, he is at Medidata Solutions developing new ways of leveraging LLM and traditional ML methods in drug development
Dr. Mridula Pore
Mridula is co-founder and chair of Peppy, a leading Series B B2B health-tech business. Previously, she held leadership roles at Sandoz and McKinsey. Based in London, Mridula has a Ph.D. in Chemical Engineering and MBA from MIT. Her entrepreneurial spirit and deep industry knowledge will greatly benefit our mission
Dr. Matthias Wernicke
Matthias, currently the Managing Director of Merck Healthcare Germany, boasts 25 years in Pharma and Healthcare, with significant stints at McKinsey and Merck. An Oxford alumnus with a BA in PPE and a DPhil in Economics, his strategic vision and industry experience are invaluable assets